Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Encarnacion JA, Dominguez-Gil B, Pellicer C, Fernandez R, Moya J, Ortin A, Manso C, Fernandez M, Lucas C, Jimena R, Lopez N, Alonso-Romero JL, Ruiz P, Ortega-Lopez ND, Royo-Villanova M. Midazolam prescription as a trigger for potential deceased donor identification outside the ICU: a prospective feasibility study. BMC Palliat Care. 2026 May 29. doi: 10.1186/s12904-026-02163-4. Online ahead of print. PubMed PMID: 42215950.
AÑO: 2026; IF: 3.7
Orenes-Piñero E., Ros-Martínez S., Alonso-Romero J.L., Ortega-García J.A. Immunoscore and beyond: evolution and clinical integration of immune contexture-based biomarkers across solid tumours. Frontiers in Immunology. 2026. 17. 10.3389/fimmu.2026.1832715
AÑO: 2026; IF: 7.0
Ibanez N, Abrisqueta J, Encarnacion JA, Hernandez Q. Neoadjuvant therapy and the Watch and Wait strategy in rectal cancer diagnosed after sex reassignment surgery. Cir Esp (Engl Ed). 2026 Feb 5:800299. doi: 10.1016/j.cireng.2026.800299. Online ahead of print. No abstract available. PubMed PMID: 41654118.
AÑO: 2026; IF: 1.5
Encarnación J.A., Ibáñez N., De la Fuente I., Ruiz P., González S., Quiles B., Sánchez M., Bautista Y., Rodríguez C., Nadal J.A., Marín M., Marín-Zafra G., Guirao M., Hernández Q., Abrisqueta J., Abellán I., Montoya M., Ono A., Carbonell G., Frutos L., Ortiz E., Manso C., Royo-Villanova M., Alonso-Romero J.L. Clinical Complete Response and Organ Preservation Strategies in Rectal Cancer: A Real-World Single-Center Experience Clinical Complete Response and Organ Preservation in Rectal Cancer. Cancers. March 2026. 18. 10.3390/cancers18050763
AÑO: 2026; IF: 4.8
Lopez-Tarruella S, Guerrero-Zotano A, Antolin S, Cruz J, Martinez P, Rodriguez CA, Falo C, Rodriguez-Lescure A, Adrover E, Hernandez M, Andres R, Chacon JI, Alonso Romero JL, Miguel A, Gomez-Raposo C, Margeli M, Gonzalez I, Guerra JA, Anton A, Tibau A, Miralles JJ, Escudero MJ, Bezares S, Rojo F, Alvarez I. Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM). Ther Adv Med Oncol. 2026 Feb 20;18:17588359261421813. doi: 10.1177/17588359261421813. eCollection 2026. PubMed PMID: 41732657; PubMed Central PMCID: PMC12924966.
AÑO: 2026; IF: 4.1
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII